UNSPSC 51283717: Cefminox sodium

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51283717

Definition

This classification denotes the sodium form of a cephalosporin antibiotic with the molecular formula C16H21N7O7S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PW08Y13465, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((2s)-2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r,7s)- but more generally known as cefminox, which bears US NIH Compound Identifier 71141.

Read the full definition

European Medicines Agency schedules Cefminox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07400MIG. The term CEFMINOX is an International Non-Proprietary Name. CEFMINOX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cefminox sodium under HS 29419000 and SITC 54139. As of Q4 2014, CEFMINOX SODIUM remains US FDA's Preferred Term for this commodity. Cefminox sodium bears US NLM identifiers UMLS ID C1529767 and NCI Concept Code C98223.

SMILES: CN1C(NNN1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSC[C@H](C(=O)O)N)OC)SC2)C(=O)[O-].[NA+].

About UNSPSC 51283717

UNSPSC 51283717 Cefminox sodium (Commodity) does not see active state and local procurement activity aligned with its pharmaceutical scope. The recent opportunities tagged to this code involve naloxone procurement, direct-to-manufacturer prescription programs, emergency medical supplies, and generic pharmaceuticals through cooperative purchasing — none of which are cefminox sodium, a third-generation cephalosporin antibiotic. The code appears to be a mismatch across recent state and local solicitations, suggesting minimal or no current demand for cefminox sodium specifically among state departments, counties, cities, or cooperative purchasing consortiums.

The four recent opportunities in the data reflect broader pharmaceutical and medical supply procurement but do not target cefminox sodium. Seminole County, Florida (IFB60459723LAS, response due July 26, 2023) solicited naloxone and drug deactivation systems; the Texas Health and Human Services Commission issued an RFI (HHS0017013, April 3, 2026) exploring direct-to-manufacturer prescription programs; the City of Tampa (26P00145, due March 13, 2026) sought emergency medical and first aid supplies for its fire department; and the Minnesota Multistate Cooperative Purchasing Alliance (S1070000015802, due March 26, 2026) established contracts for generic multi-source pharmaceuticals and OTC products. This concentration of activity in naloxone, emergency response supplies, and generic pharmaceutical cooperative purchasing suggests that state and local procurement under pharmaceutical codes favors high-volume, low-cost generics and public-health-focused drugs rather than specialty antibiotics. Vendors pursuing this code should verify whether state and local health departments, prisons, hospitals, or clinics maintain separate demand signals for cefminox sodium that do not appear in recent public solicitations.

Quick answers

What is UNSPSC 51283717?

UNSPSC 51283717 is Cefminox sodium, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51283717?

UNSPSC 51283717 maps to 1 NIGP code, 26908 Anti-Infective Agents.

On GovTribe

See everything under UNSPSC 51283717

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code